Oral bacteria as potential probiotics for the pharyngeal mucosa
- PMID: 20418429
- PMCID: PMC2893495
- DOI: 10.1128/AEM.00109-10
Oral bacteria as potential probiotics for the pharyngeal mucosa
Abstract
The research described here was aimed at the selection of oral bacteria that displayed properties compatible with their potential use as probiotics for the pharyngeal mucosa. We included in the study 56 bacteria newly isolated from the pharynges of healthy donors, which were identified at the intraspecies level and characterized in vitro for their probiotic potential. The experiments led us to select two potential probiotic bacterial strains (Streptococcus salivarius RS1 and ST3) and to compare them with the prototype oral probiotic S. salivarius strain K12. All three strains efficiently bound to FaDu human epithelial pharyngeal cells and thereby antagonized Streptococcus pyogenes adhesion and growth. All were sensitive to a variety of antibiotics routinely used for the control of upper respiratory tract infections. Immunological in vitro testing on a FaDu layer revealed different responses to RS1, ST3, and K12. RS1 and ST3 modulated NF-kappaB activation and biased proinflammatory cytokines at baseline and after interleukin-1beta (IL-1beta) induction. In conclusion, we suggest that the selected commensal streptococci represent potential pharyngeal probiotic candidates. They could display a good degree of adaptation to the host and possess potential immunomodulatory and anti-inflammatory properties.
Figures
Similar articles
-
In vitro functional and immunomodulatory properties of the Lactobacillus helveticus MIMLh5-Streptococcus salivarius ST3 association that are relevant to the development of a pharyngeal probiotic product.Appl Environ Microbiol. 2012 Jun;78(12):4209-16. doi: 10.1128/AEM.00325-12. Epub 2012 Apr 13. Appl Environ Microbiol. 2012. PMID: 22504812 Free PMC article.
-
A dairy bacterium displays in vitro probiotic properties for the pharyngeal mucosa by antagonizing group A streptococci and modulating the immune response.Infect Immun. 2010 Nov;78(11):4734-43. doi: 10.1128/IAI.00559-10. Epub 2010 Aug 23. Infect Immun. 2010. PMID: 20732995 Free PMC article.
-
Antagonistic effects of Streptococcus and Lactobacillus probiotics in pharyngeal biofilms.Lett Appl Microbiol. 2019 Apr;68(4):303-312. doi: 10.1111/lam.13133. Epub 2019 Mar 13. Lett Appl Microbiol. 2019. PMID: 30776138
-
Developing oral probiotics from Streptococcus salivarius.Future Microbiol. 2012 Dec;7(12):1355-71. doi: 10.2217/fmb.12.113. Future Microbiol. 2012. PMID: 23231486 Review.
-
Streptococcal bacteriocins and the case for Streptococcus salivarius as model oral probiotics.Future Microbiol. 2009 Sep;4(7):819-35. doi: 10.2217/fmb.09.61. Future Microbiol. 2009. PMID: 19722837 Review.
Cited by
-
Immunomodulatory streptococci that inhibit CXCL8 secretion and NFκB activation are common members of the oral microbiota.J Med Microbiol. 2021 Mar;70(3):001329. doi: 10.1099/jmm.0.001329. Epub 2021 Mar 18. J Med Microbiol. 2021. PMID: 33734952 Free PMC article.
-
Persistence of the oral probiotic Streptococcus salivarius M18 is dose dependent and megaplasmid transfer can augment their bacteriocin production and adhesion characteristics.PLoS One. 2013 Jun 13;8(6):e65991. doi: 10.1371/journal.pone.0065991. Print 2013. PLoS One. 2013. PMID: 23785463 Free PMC article.
-
Beneficial effects of probiotics in upper respiratory tract infections and their mechanical actions to antagonize pathogens.J Appl Microbiol. 2012 Dec;113(6):1305-18. doi: 10.1111/j.1365-2672.2012.05394.x. Epub 2012 Aug 3. J Appl Microbiol. 2012. PMID: 22788970 Free PMC article. Review.
-
Contribution of Streptococcus pseudopneumoniae and Streptococcus salivarius to vocal fold mucosal integrity and function.Dis Model Mech. 2024 Jul 1;17(7):dmm050670. doi: 10.1242/dmm.050670. Epub 2024 Jul 16. Dis Model Mech. 2024. PMID: 38903015 Free PMC article.
-
S-layer protein mediates the stimulatory effect of Lactobacillus helveticus MIMLh5 on innate immunity.Appl Environ Microbiol. 2013 Feb;79(4):1221-31. doi: 10.1128/AEM.03056-12. Epub 2012 Dec 7. Appl Environ Microbiol. 2013. PMID: 23220964 Free PMC article.
References
-
- Abbot, E. L., W. D. Smith, G. P. Siou, C. Chiriboga, R. J. Smith, J. A. Wilson, B. H. Hirst, and M. A. Kehoe. 2007. Pili mediate specific adhesion of Streptococcus pyogenes to human tonsil and skin. Cell. Microbiol. 9:1822-1833. - PubMed
-
- Afek, S., A. D. Sperber, and Y. Almog. 2004. Carcinoma of the colon presenting as Streptococcus salivarius sepsis. J. Clin. Gastroenterol. 38:86-87. - PubMed
-
- Ahmed, R., T. Hassall, B. Morland, and J. Gray. 2003. Viridans streptococcus bacteremia in children on chemotherapy for cancer: an underestimated problem. Pediatr. Hematol. Oncol. 20:439-444. - PubMed
-
- Beimfohr, C., W. Ludwig, and K. H. Schleifer. 1997. Rapid genotypic differentiation of Lactococcus lactis subspecies and biovar. Syst. Appl. Microbiol. 20:216-221.
-
- Bek-Thomsen, M., H. Tettelin, I. Hance, K. E. Nelson, and M. Kilian. 2008. Population diversity and dynamics of Streptococcus mitis, Streptococcus oralis, and Streptococcus infantis in the upper respiratory tracts of adults, determined by a nonculture strategy. Infect. Immun. 76:1889-1896. - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources